Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria J Ribal

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder CancerElaine Chang, Noah M Hahn, Seth P Lerner, et al.
European Urology Open Science|April 4, 2024
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER PlatformPawel Rajwa, Angelika Borkowetz, Thomas Abbott, et al.
Nature Reviews. Urology|May 29, 2020
Introducing PIONEER: a project to harness big data in prostate cancer researchMuhammad Imran Omar, Monique J Roobol, Maria J Ribal, et al.
Nature Reviews. Urology|June 27, 2020
Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer researchMuhammad Imran Omar, Monique J Roobol, Maria J Ribal, et al.
European Urology|May 8, 2020
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 EraMaria J Ribal, Philip Cornford, Alberto Briganti, et al.
European Urology Focus|May 16, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
International Urology and Nephrology|November 19, 2023
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology|January 20, 2023
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology|October 8, 2019
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)Thomas B L Lam, Steven MacLennan, Peter-Paul M Willemse, et al.
European Urology Oncology|May 21, 2025
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder CancerRoberto Contieri, Alberto Martini, Irene J Beijert, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder CancerElaine Chang, Noah M Hahn, Seth P Lerner, et al.
European Urology Open Science|April 4, 2024
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER PlatformPawel Rajwa, Angelika Borkowetz, Thomas Abbott, et al.
Nature Reviews. Urology|May 29, 2020
Introducing PIONEER: a project to harness big data in prostate cancer researchMuhammad Imran Omar, Monique J Roobol, Maria J Ribal, et al.
Nature Reviews. Urology|June 27, 2020
Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer researchMuhammad Imran Omar, Monique J Roobol, Maria J Ribal, et al.
European Urology|May 8, 2020
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 EraMaria J Ribal, Philip Cornford, Alberto Briganti, et al.
European Urology Focus|May 16, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
International Urology and Nephrology|November 19, 2023
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology|January 20, 2023
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology|October 8, 2019
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)Thomas B L Lam, Steven MacLennan, Peter-Paul M Willemse, et al.
European Urology Oncology|May 21, 2025
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder CancerRoberto Contieri, Alberto Martini, Irene J Beijert, et al.
Pageof 9